Treatment of heart failure with preserved ejection fraction

Current Treatment Options in Cardiovascular Medicine

Volumn 11, Issue 1, 2009, Pages 79-87

  Borlaug, Barry A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHLORTALIDONE; DIGOXIN; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LISINOPRIL; LOSARTAN; MINERALOCORTICOID ANTAGONIST; NEBIVOLOL; NITRATE; PERINDOPRIL; PLACEBO; RANOLAZINE; SILDENAFIL; SPIRONOLACTONE; VALSARTAN; VERAPAMIL;

CLINICAL PROTOCOL; CLINICAL TRIAL; DIASTOLIC DYSFUNCTION; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; EXERCISE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE COMPLIANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART RATE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; UNITED STATES;

EID: 58649109169     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-009-0009-5     Document Type: Review

References (54)

1. Owan TE, Hodge DO, Herges RM, et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355: 251-259.
2. Bhatia RS, Tu JV, Lee DS, et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355: 260-269.
3. Hunt SA, Abraham WT, Chin MH, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112: E154-e235.
4. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003, 362: 777-781.
5. Cleland JG, Tendera M, Adamus J, et al.: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006, 27: 2338-2345.
6. Massie BM, Carson PE, McMurray JJ, et al.: Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008 [Epub ahead of print].
7. Borlaug BA, Kass DA: Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med 2006, 16: 273-279.
8. Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350: 1953-1959.
9. Lam CS, Roger VL, Rodeheffer RJ, et al.: Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007, 115: 1982-1990.
10. Westermann D, Kasner M, Steendijk P, et al.: Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008, 117: 2051-2060.
11. Glantz SA, Parmley WW: Factors which affect the diastolic pressure-volume curve. Circ Res 1978, 42: 171-180.
12. Leite-Moreira AF, Correia-Pinto J, Gillebert TC: Afterload induced changes in myocardial relaxation: A mechanism for diastolic dysfunction. Cardiovasc Res 1999, 43: 344-353.
13. Borlaug BA, Melenovsky V, Redfield MM, et al.: Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol 2007, 50: 1570-1577.
14. Solomon SD, Janardhanan R, Verma A, et al.: Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. Lancet 2007, 369: 2079-2087.
15. Kass DA, Midei M, Brinker J, Maughan WL: Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans. Circulation 1990, 81: 447-460.
16. Choudhury L, Gheorghiade M, Bonow RO: Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol 2002, 89: 719-722.
17. Kramer K, Kirkman P, Kitzman D, Little WC: Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 2000, 140: 451-455.
18. Chen CH, Nakayama M, Nevo E, et al.: Coupled systolic-ventricular and vascular stiffening with age: Implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998, 32: 1221-1227.
19. Redfield MM, Jacobsen SJ, Borlaug BA, et al.: Age- and gender-related ventricular-vascular stiffening: A community-based study. Circulation 2005, 112: 2254-2262.
20. Borlaug BA, Kass DA: Ventricular-vascular interaction in heart failure. Heart Fail Clin 2008, 4: 23-36.
21. Klapholz M, Maurer M, Lowe AM, et al.: Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York Heart Failure Registry. J Am Coll Cardiol 2004, 43: 1432-1438.
22. Gandhi SK, Powers JC, Nomeir AM, et al.: The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344: 17-22.
23. Kawaguchi M, Hay I, Fetics B, Kass DA: Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: Implications for systolic and diastolic reserve limitations. Circulation 2003, 107: 714-720.
24. Hundley WG, Kitzman DW, Morgan TM, et al.: Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001, 38: 796-802.
25. Warner JG Jr, Metzger DC, Kitzman DW, et al.: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33: 1567-1572.
26. Little WC, Zile MR, Klein A, et al.: Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction. Am J Cardiol 2006, 98: 383-385.
27. Shapiro BP, Lam CS, Patel JB, et al.: Acute and chronic ventricular-arterial coupling in systole and diastole. Insights from an elderly hypertensive model. Hypertension 2007, 50: 503-511.
28. Kitzman DW, Higginbotham MB, Cobb FR, et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: Failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17: 1065-1072.
29. Borlaug BA, Melenovsky V, Russell SD, et al.: Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114: 2138-2147.
30. Borlaug BA, Lam CSP, Olson TP, et al.: Cardiovascular reserve function in heart failure with preserved ejection fraction: Systolic versus diastolic determinants [abstract]. Circulation 2008, 118: S1022.
31. Brubaker PH, Joo KC, Stewart KP, et al.: Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 2006, 26: 86-89.
32. Smith CS, Bottomley PA, Schulman SP, et al.: Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006, 114: 1151-1158.
33. Yip G, Wang M, Zhang Y, et al.: Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: Time for a redefinition ? Heart 2002, 87: 121-125.
34. Yu CM, Lin H, Yang H, et al.: Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002, 105: 1195-1201.
35. Wang J, Khoury DS, Yue Y, et al.: Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 2008, 29: 1283-1289.
36. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH: Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005, 111: 2306-2312.
37. Melenovsky V, Borlaug BA, Rosen B, et al.: Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: The role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007, 49: 198-207.
38. Aurigemma GP, Zile MR, Gaasch WH: Contractile behavior of the left ventricle in diastolic heart failure: With emphasis on regional systolic function. Circulation 2006, 113: 296-304.
39. Borlaug BA, Lam CS, Roger VL, et al.: Myocardial contractile dysfunction in heart failure with preserved ejection fraction [abstract]. Circulation 2008, 118: S1021.
40. McMurray JJ, Carson PE, Komajda M, et al.: Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 2008, 10: 149-156.
41. Aronow WS, Kronzon I: Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993, 71: 602-604.
42. Little WC, Brucks S: Therapy for diastolic heart failure. Prog Cardiovasc Dis 2005, 47: 380-388.
43. Flather MD, Shibata MC, Coats AJ, et al.: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005, 26: 215-225.
44. Ghio S, Magrini G, Serio A, et al.: Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: Results of the SENIORS echocardiographic substudy. Eur Heart J 2006, 27: 562-568.
45. Chen HH: Aeart failure: a state of brain natriuretic peptide deficiency or resistance or both! J Am Coll Cardiol 2007, 49: 1089-1091.
46. Davis BR, Kostis JB, Simpson LM, et al.: Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2008 [Epub ahead of print].
47. Setaro JF, Zaret BL, Schulman DS, et al.: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66: 981-986.
48. Ahmed A, Rich MW, Fleg JL, et al.: Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary digitalis investigation group trial. Circulation 2006, 114: 397-403.
49. Fukuta H, Sane DC, Brucks S, Little WC: Statin therapy may be associated with lower mortality in patients with diastolic heart failure: A preliminary report. Circulation 2005, 112: 357-363.
50. Brucks S, Little WC, Chao T, et al.: Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004, 93: 1055-1057.
51. Fung JW, Li TS, Choy DK, et al.: Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002, 121: 422-429.
52. van Heerebeek L, Borbely A, Niessen HW, et al.: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113: 1966-1973.
53. Sossalla S, Wagner S, Rasenack EC, et al.: Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 2008, 45: 32-43.
54. Nagueh SF: Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol 2008, 51: 18-22.